ESMO-ESGO 卵巢癌共识会议推荐:病理与分子生物学、早期与晚期、交界性肿瘤及复发疾病
ESMO 与 ESGO 于 2018 年 4 月 12 日至 14 日在意大利米兰召开卵巢癌共识会议,由 40 位多学科专家组成专家组,围绕病理与分子生物学、早期与交界性肿瘤、晚期疾病及复发疾病四个领域共 5 个临床相关问题,基于系统检索的文献证据形成推荐并达成共识。
要点
- 共识会议涵盖卵巢癌病理与分子生物学、早期与交界性肿瘤、晚期及复发疾病四个领域。
- 专家组由 40 位卵巢癌管理多学科专家组成,会前完成系统文献检索与复习。
- 推荐基于当时最佳证据与专家共识,每条推荐附证据摘要。
核心结论
- ESMO-ESGO 共识会议针对卵巢癌四个领域共 5 个临床问题形成推荐,推荐基于最佳可得证据与专家共识。
研究设计与样本
- ESMO 与 ESGO 联合制定指南推荐,作为两学会改善欧洲癌症患者诊疗质量使命的一部分。
- ESMO-ESGO 卵巢癌共识会议于 2018 年 4 月 12 日至 14 日在意大利米兰举行,由 40 位卵巢癌管理多学科专家组成专家组。
- 会前专家组围绕病理与分子生物学、早期与交界性肿瘤、晚期疾病及复发疾病四个领域共 5 个临床相关问题,基于系统检索识别的相关科学文献进行复习。
- 会议期间专家组针对每个具体问题形成推荐并达成共识。
临床怎么用
- 本文呈现 ESMO-ESGO 共识会议的推荐,并附支持每条推荐的证据摘要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The development of guidelines recommendations is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission of both societies to improve the quality of care for patients with cancer across Europe. ESMO and ESGO jointly developed clinically relevant and evidence-based recommendations in several selected areas in order to improve the quality of care for women with ovarian cancer. The ESMO-ESGO consensus conference on ovarian cancer was held on 12-14 April 2018 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of ovarian cancer. Before the conference, the expert panel worked on five clinically relevant questions regarding ovarian cancer relating to each of the following four areas: pathology and molecular biology, early-stage and borderline tumours, advanced stage disease and recurrent disease. Relevant scientific literature, as identified using a systematic search, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. The recommendations presented here are thus based on the best available evidence and expert agreement. This article presents the recommendations of this ESMO-ESGO consensus conference, together with a summary of evidence supporting each recommendation.
引用
- Colombo N, Sessa C, du Bois A, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol. 2019. PMID: 31046081. doi:10.1093/annonc/mdz062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。